Niall Balfour, CEO, Tower Cold Chain, discusses the current challenges in the pharmaceutical cold chain and highlights how pharmaceutical manufacturers can ensure safe delivery of shipments, from mass-market to clinical trials.
Jon Carlisle, encapsulation technical service manager, Natoli Encapsulation Division, examines the function and optimal set-up of tamper-style encapulsation machines to increase product yield.
Rebekah Jordan gives a review of the recent CPhI Frankfurt 2022 event: observing noteworthy innovations, key themes across the industry, and the latest developments in pharma aiming to tackle trending issues.
BioIVT’s Trevor Smith, MS, MBA, product manager, immune cells, describes necessary considerations when preparing to manufacture a cell or gene therapy, from starting materials to safety endpoints.
Katie Farley, director, product management at MasterControl, explores five pharmaceutical trends, what’s driving them, and how adopting them can lead to eliminating manufacturing errors, enhancing performance, and gaining a competitive advantage.
Abbie Fisher, associate at European Intellectual Property Firm, Withers & Rogers, discusses patenting a new frontier in personalised medicine with AI-powered biomarker discovery.
Emmanuel Abate, president Genomic Medicine and head of Sustainability, Cytiva, reflects on the developments of the biotech industry in 2022 and despite the manufacturing challenges that remain, the focus on sustainable solutions must not be ignored.
In this editor's desk, Rebekah Jordan shares her views on the achievements within pharma sustainability in 2022, its criticality in pharma investment opportunities, and what's still to be done.
BD and Biocorp joined forces to improve the outcomes and adherence of self-administered drugs through connected drug delivery, by combining the use of digital technology with prefillable syringes.
In this case study, Zambon worked extensively to redefine the product profile due to the introduction of new raw material suppliers, with the concurrent aim to achieve an improvement of PSD with minimisation of fines and big agglomerates.
Adnan Khan, manager of pharma industries at Beckhoff UK, discusses the challenges of pharmaceutical production lines and how next-generation motion can help.
Mark Hilhorst, CEO of Jekson Vision, provides insight into the stringent quality checks needed that are crucial to improve patient safety in the pharma market, and how automation solutions can help with this, while meeting growing market demand.
